YahooOctober 9, 2026 at 1:32 PM NY18 Days Ago
Collegium Pharmaceutical Outlook Supported by ADHD Trends, Low Generic Drug Risk, Oppenheimer Says
Collegium Pharmaceutical (COLL) should benefit from continued strength in its attention-deficit/hype
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Yahoo
